Cargando…

Biologics in Severe Eosinophilic Asthma: Three-Year Follow-Up in a SANI Single Center

Introduction: Biologic drugs have dramatically improved severe eosinophilic asthma (SEA) outcomes. Our aim was to evaluate the long-term efficacy of biological therapy in SEA in a real-life setting and to identify the predictors for switching to another biological drug in patients with poor asthma c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Solidoro, Paolo, Nicola, Stefania, Ridolfi, Irene, Canonica, Giorgio Walter, Blasi, Francesco, Paggiaro, Pierluigi, Heffler, Enrico, Bagnasco, Diego, Patrucco, Filippo, Ribolla, Fulvia, Bucca, Caterina, Rolla, Giovanni, Albera, Carlo, Brussino, Luisa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8869384/ https://www.ncbi.nlm.nih.gov/pubmed/35203409 http://dx.doi.org/10.3390/biomedicines10020200

Ejemplares similares

Frequency of Tiotropium Bromide Use and Clinical Features of Patients with Severe Asthma in a Real-Life Setting: Data from the Severe Asthma Network in Italy (SANI) Registry
por: Puggioni, Francesca, et al.
Publicado: (2020)

Predictors of reversible airway obstruction with omalizumab in severe asthma: a real-life study
por: Solidoro, Paolo, et al.
Publicado: (2019)

Sex Differences in Severe Asthma: Results From Severe Asthma Network in Italy-SANI
por: Senna, Gianenrico, et al.
Publicado: (2020)

Economic impact of mepolizumab in uncontrolled severe eosinophilic asthma, in real life()
por: Bagnasco, Diego, et al.
Publicado: (2021)

Triple Therapy in COPD: Can We Welcome the Reduction in Cardiovascular Risk and Mortality?
por: Solidoro, Paolo, et al.
Publicado: (2022)

SANI-Severe Asthma Network in Italy: a way forward to monitor severe asthma
por: Senna, G., et al.
Publicado: (2017)

Eosinophils Target Therapy for Severe Asthma: Critical Points
por: Brussino, L., et al.
Publicado: (2018)

Shadow cost of oral corticosteroids-related adverse events: A pharmacoeconomic evaluation applied to real-life data from the Severe Asthma Network in Italy (SANI) registry
por: Canonica, Giorgio Walter, et al.
Publicado: (2019)

Oral CorticoSteroid sparing with biologics in severe asthma: A remark of the Severe Asthma Network in Italy (SANI)
por: Canonica, Giorgio Walter, et al.
Publicado: (2020)

IL-17 Promotes Nitric Oxide Production in Non-Small-Cell Lung Cancer
por: Nicola, Stefania, et al.
Publicado: (2021)

Is it severe asthma or asthma with severe comorbidities?
por: Brussino, Luisa, et al.
Publicado: (2017)

Asthmatic Patients with Vitamin D Deficiency have Decreased Exacerbations after Vitamin Replacement
por: Solidoro, Paolo, et al.
Publicado: (2017)

The North-Western Italian experience with anti IL-5 therapy amd comparison with regulatory trials
por: Bagnasco, Diego, et al.
Publicado: (2018)

Relevance of Smoking Habit in Severe Asthma Patients: Evidence from the Severe Asthma Network in Italy (SANI) Registry
por: Caminati, Marco, et al.
Publicado: (2022)

COPD, but Not Asthma, Is Associated with Worse Outcomes in COVID-19: Real-Life Data from Four Main Centers in Northwest Italy
por: Nicola, Stefania, et al.
Publicado: (2022)

Patient and physician perspectives on biological treatment in severe asthma: a Severe Asthma Network Italy survey
por: Crimi, Claudia, et al.
Publicado: (2023)

Critical evaluation of asthma biomarkers in clinical practice
por: Guida, Giuseppe, et al.
Publicado: (2022)

Severe asthma: One disease and multiple definitions
por: Bagnasco, Diego, et al.
Publicado: (2021)

Gastric Juice Expression of Th-17 and T-Reg Related Cytokines in Scleroderma Esophageal Involvement
por: Nicola, Stefania, et al.
Publicado: (2020)

Interleukin-5 pathway inhibition in the treatment of eosinophilic respiratory disorders: evidence and unmet needs
por: Varricchi, Gilda, et al.
Publicado: (2016)

Severe vitamin D deficiency is associated with frequent exacerbations and hospitalization in COPD patients
por: Malinovschi, Andrei, et al.
Publicado: (2014)

Release of Type 2 Cytokines by Epithelial Cells of Nasal Polyps
por: Boita, Monica, et al.
Publicado: (2016)

Reslizumab and Eosinophilic Asthma: One Step Closer to Precision Medicine?
por: Varricchi, Gilda, et al.
Publicado: (2017)

Retraction: Determinants of self-reported adherence to inhaler therapy in patients with chronic obstructive pulmonary disease
por: Aredano, Ilaria, et al.
Publicado: (2020)

Determinants of self-reported adherence to inhaler therapy in patients with chronic obstructive pulmonary disease
por: Aredano, Ilaria, et al.
Publicado: (2020)

Manifesto on the overuse of SABA in the management of asthma: new approaches and new strategies
por: Canonica, Giorgio Walter, et al.
Publicado: (2021)

325 Exercise-induced Airway Obstruction and Vitamin D Deficiency
por: Varenni, Davide, et al.
Publicado: (2012)

“Characteristics of patients admitted to emergency department for asthma attack: a real-LIFE study”
por: Losappio, Laura, et al.
Publicado: (2019)

Long-Term Efficacy of Mepolizumab at 3 Years in Patients with Severe Asthma: Comparison with Clinical Trials and Super Responders
por: Bagnasco, Diego, et al.
Publicado: (2023)

Twelve-month effects of everolimus on renal and lung function in lung transplantation: differences in chronic lung allograft dysfunction phenotypes
por: Patrucco, Filippo, et al.
Publicado: (2021)

Defining type 2 asthma and patients eligible for dupilumab in Italy: a biomarker-based analysis
por: Canonica, Giorgio Walter, et al.
Publicado: (2021)

Mepolizumab in the management of severe eosinophilic asthma in adults: current evidence and practical experience
por: Varricchi, Gilda, et al.
Publicado: (2016)

Cellular and humoral cytomegalovirus immunity changes in one-year combined prophylaxis after lung transplantation: suggestions from and for clinical practice
por: Solidoro, Paolo, et al.
Publicado: (2020)

Prospective Italian real‐world study of mepolizumab in severe eosinophilic asthma validates retrospective outcome reports
por: Pini, Laura, et al.
Publicado: (2021)

Choosing wisely: practical considerations on treatment efficacy and safety of asthma in the elderly
por: Scichilone, Nicola, et al.
Publicado: (2015)

Choosing wisely in Allergology: a Slow Medicine approach to the discipline promoted by the Italian Society of Allergy, Asthma and Clinical Immunology (SIAAIC)
por: Heffler, Enrico, et al.
Publicado: (2015)

Laryngeal Spasm Mimicking Asthma and Vitamin D Deficiency
por: Masoero, Monica, et al.
Publicado: (2014)

Personalized Approach to Severe Asthma
por: Heffler, Enrico, et al.
Publicado: (2018)

Targeted therapy in severe asthma today: focus on immunoglobulin E
por: Pelaia, Girolamo, et al.
Publicado: (2017)

31 Nasal Nitric Oxide and Nasal Polyposis as Determinants of Asthma Control
por: Heffler, Enrico, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_7mildlb83ljdnret7eksm642mr